Select for export Natural language signatures of psilocybin microdosing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06170-0 PubMed 35676541 Copy citation Copy BibTeX Psychopharmacology 2022-06-08 Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M Europe PMC Published psilocybin MicrodosingWellbeingCreativity Other More
Select for export An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/ffgc.2022.813998 Copy citation Copy BibTeX Frontiers in Forests and Global Change 2022-05-22 Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout OpenAlex Published psilocybinpsilocin AddictionPharmacologyReview Article Review Article More
Select for export Receptor binding profiles and behavioral effects of psilocybin analogs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.2022.36.s1.r3639 Copy citation Copy BibTeX The FASEB Journal 2022-04-30 Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1540-9907 Copy citation Copy BibTeX Zeitschrift für Phytotherapie 2022-03-31 Antonia Kuhn, Matthias F. Melzig OpenAlex Published psilocybinpsilocin DepressionPharmacology Other More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.788155 PubMed 35431912 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-30 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J Europe PMC Published psilocybin DepressionEmotional ProcessingMystical Experience Randomized Controlled Trial More
Select for export Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.841648 PubMed 35355714 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-08 McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S Europe PMC Published psilocybin Mystical ExperienceHealthy Volunteers Qualitative Study More
Select for export Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06020-5 PubMed 35234983 Copy citation Copy BibTeX Psychopharmacology 2022-03-01 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N Europe PMC Published psilocybinpsilocin DepressionReceptor Pharmacology Other More
Select for export The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073758 PubMed 35253518 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-02-28 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. Europe PMC Published psilocybin Mechanism of ActionPsychological FlexibilityObservational Study Observational Study More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06066-z PubMed 35076721 Copy citation Copy BibTeX Psychopharmacology 2022-01-24 Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y Europe PMC Published psilocybin Clinical TrialHealthy Volunteers Clinical Trial More
Select for export Analysis of recreational psychedelic substance use experiences classified by substance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06062-3 PubMed 35031816 Copy citation Copy BibTeX Psychopharmacology 2022-01-14 Hase A, Erdmann M, Limbach V, Hasler G. Europe PMC Published psilocybin AddictionBiomarkersEmotional Processing Clinical Trial More
Select for export MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058923 PubMed 34983249 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin Observational StudyAdolescentsSafety Observational Study More
Select for export Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211066714 PubMed 34983261 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin DepressionAddictionChronic Pain Observational Study More
Select for export The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211064720 PubMed 35090363 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-03 Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J Europe PMC Published psilocybin DepressionReceptor PharmacologyEmotional Processing Randomized Controlled Trial More
Select for export Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100335 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2022.100407 Copy citation Copy BibTeX Neuroscience Applied 2021-12-31 Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Psilocybin: a psychedelic alternative to antidepressants? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1211/pj.2022.1.169269 Copy citation Copy BibTeX Pharmaceutical journal/The pharmaceutical journal 2021-12-31 Authors unavailable OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.